Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04815239 · ClinicalTrials.gov registry record · NA

Early Intervention for Youth at High Risk for Bipolar Disorder

A NA study of Bipolar Disorder, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04815239: Recruiting NA study of Bipolar Disorder, sponsored by University of Pittsburgh.

NCT04815239 is a NA study of Bipolar Disorder that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 120 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04815239, a NA study of Bipolar Disorder, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Investigators will conduct a confirmatory efficacy trial of Interpersonal and Social Rhythm Therapy (IPSRT) delivered via telehealth for offspring of bipolar parents (OBP; age 12-18, n=120) at elevated risk for BP onset via risk calculator score. All participants receive a baseline clinical assessment of psychiatric symptoms and sleep disturbance (via objective and subjective methods), followed by a feedback session. Youth are then randomized to receive 8 sessions of IPSRT or a manualized Healthy Lifestyle Behaviors Program (HL) delivered via secure videoconference. As clinically indicated, youth are offered Community Treatment Referral (CTR) for any psychiatric symptoms/disorders identified at intake. Primary outcome domains over 18 months include mania and affective lability. Investigators will also further investigate the hypothesized mechanism underlying IPSRT (i.e., sleep/circadian disruption) across levels of analysis, and the contribution of interpersonal stress to sleep/circadian disruptions. Application of Implementation Science methods throughout maximizes ultimate scalability and feasibility if efficacious. Investigators will also examine whether passive cellphone sensing may serve as a portable, cost-effective measure of mechanisms and outcomes to enhance ultimate dissemination.

Primary Outcome

Adolescent Longitudinal Interval Follow-Up Evaluation (ALIFE) Psychiatric Status Ratings (PSR; Range 1-6)

Conditions Studied

Interventions

  • BEHAVIORAL Interpersonal and Social Rhythm Therapy (IPSRT)
  • BEHAVIORAL The Healthy Lifestyle Behavior Intervention (HL)

Study Locations (1)

Pennsylvania

  • Nicole Arnold - Pittsburgh

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-09-01
Est. Completion 2027-04-30
Phase NA
University of Pittsburgh

1,238 total trials

What NCT04815239 shows while recruiting

NCT04815239 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Interpersonal and Social Rhythm Therapy (IPSRT) is the first listed.

NCT04815239 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04815239 about?

NCT04815239 is a clinical study titled "Early Intervention for Youth at High Risk for Bipolar Disorder". Investigators will conduct a confirmatory efficacy trial of Interpersonal and Social Rhythm Therapy (IPSRT) delivered via telehealth for offspring of bipolar parents (OBP; age 12-18, n=120) at elevated risk for BP onset via risk calculator score. All participants receive a baseline clinical assessme...

What is the current status of trial NCT04815239?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-09-01. Estimated completion is 2027-04-30.

What conditions does trial NCT04815239 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT04815239?

The interventions under investigation include: Interpersonal and Social Rhythm Therapy (IPSRT) (BEHAVIORAL), The Healthy Lifestyle Behavior Intervention (HL) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04815239?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04815239 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04815239's enrollment target sits among peer trials

120 53rd of 162 higher than 106 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04815239, the US trial registry maintained by the National Library of Medicine. NCT04815239 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.